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Noninvasive Differentiation Between Active and Healed
Myocarditis by Cardiac Magnetic Resonance
Are We There Yet?*
Heiko Mahrholdt, MD, Udo Sechtem, MD, FACC
Stuttgart, GermanyMyocarditis is a common cardiac disease. It
appears to be a major cause of sudden death, and
may progress to chronic dilated cardiomyopathy.
From the clinical point of view, there are several
challenges unique to the management of patients
with myocarditis. The first challenge is to estab-
lish the diagnosis of myocarditis, which is usually
based on clinical, pathological, or a combination
of diagnostic criteria. The second challenge is to
follow the disease activity to identify patients
who may be at risk of chronic dilated cardiomy-
opathy development, which seems to be associ-
ated with ongoing myocardial inflammation (1)
and viral persistence (2).
See page 131
Cardiac magnetic resonance (CMR) has re-
cently emerged as a noninvasive tool to diagnose
myocarditis (3–6), as well as to follow its course
in living patients (3,7–9). Three features poten-
tially associated with acute myocardial inflamma-
tion may be visualized by CMR: 1) tissue edema,
which may result in an elevated T2 signal; 2)
capillary leakage, which is speculated to be asso-
ciated with an increased signal on T1-weighted
spin-echo images after gadolinium administra-
tion (elevated global relative enhancement
[gRE]); and 3) myocardial necrosis or scarring as
indicated by the presence of late gadolinium
enhancement (LGE).
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Department of Cardiology, Robert-Bosch-Medical Center,
Stuttgart, Germany.Whereas no histological proof exists that the
edema described pathologically in patients with
myocarditis (10) correlates with the T2-signal
elevation measurable in high-quality T2-
weighted MR images, the association of T2
elevation and edema has been histologically
proven in other conditions. Hence, the concept
that T2-signal elevation indicates myocardial
edema may make sense.
Hyperemia associated with capillary leakage or
muscular inflammation was also never directly
shown to be the cause of increased interstitial
uptake of gadolinium in acute myocarditis. The-
oretically, such studies could be performed in
appropriate mouse models (11) using modern
MR scanners (12). Unfortunately, there are no
data yet from such animal studies, which would
be crucial to prove the concepts of elevated T2
signal and gRE ratio to be good parameters to
demonstrate myocardial inflammation.
In contrast to the 2 previous features, the
presence of LGE has been repeatedly shown to be
associated with histological proof of acute myo-
carditis (4,8). However, if scarring is the result of
acute myocarditis it will—although often signif-
icantly smaller and sometimes beyond the reso-
lution of CMR due to scar shrinking—remain
when the acute inflammation has long subsided.
The concept of the Berlin group is that clini-
cally acute inflammation is usually associated
with T2-signal elevation, as well as an increase in
gRE ratio. Consequently, they postulate that
normalization of these 2 parameters will indicate
the absence of acute inflammation. To prove their
concept, in this issue of iJACC, Zagrosek et al.
(13) serially assessed T2 signal, gRE ratio, and
LGE at initial presentation, as well as after 18
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140onths in 36 patients diagnosed with acute
yocarditis by clinical criteria. The authors
ound an elevated T2-signal ratio during the
linically acute phase in 86% of patients, an
bnormal gRE ratio was detected in 80%, and
GE was found in 63% of patients, respectively.
uring follow-up, the T2-signal ratio decreased
rom 2.4 to 1.9, the gRE-signal ratio decreased
rom 7.6 to 4.4, and the amount of LGE de-
reased from 38% to 22% of left ventricular mass.
hese findings are in line with pervious publica-
ions describing the individual time courses of
ach of those CMR parameters (4,7,14) in myo-
arditis patients. Based on these results Zagrosek
t al. (13) conclude that the combined approach
s capable of differentiating reversible and irre-
ersible myocardial damage noninvasively. They
lso state that if none, or just 1 of T2-signal and
RE ratios is elevated, this has a negative predic-
ive value of 100% to differentiate active from
ealed myocarditis in living patients.
How should one put these results into perspec-
ive with the existing body of literature? The
argest study examining patients with clinically
uspected chronic myocarditis by CMR and his-
opathology (9) found absence of T2 elevation in
3%, and no elevated gRE ratio in 37% of those
hown to have inflammation by histology. Hence,
ne-third of patients with persisting inflamma-
ion would have elevation of 1 of these 2 CMR
arameters.
Unfortunately, the study of Gutberlet et al. (9)
oes not tell us how often both parameters were
elow the pre-defined cutoff values even though
istology indicated the persistence of inflamma-
ion. De Cobelli et al. (6) found absence of
2-ratio elevation in 78% of patients with
hronic inflammation by histopathological crite-
ia. However, these investigators did not perform
RE imaging, perhaps because the image quality
s frequently suboptimal for this pulse sequence.
aken together, these 2 studies cast serious doubt
nalysis of Most Data Available on CMR in Human Myocarditis
Ratio* gRE Ratio* La
peciﬁcity Sensitivity Speciﬁcity Sens
74% 87% 84% 76
n  23 n  117 n  48 n 
to histopathology available for myocarditis; combined approach contains T2, gR
ieker et al. (16), n  9; Laissy et al. (17), n  20; Mahrholdt et al. (4), n  32; Abdel
elli et al. (6), n  23; Mahrholdt et al. (8), n  87; Gutberlet et al. (21), n  49; Y
resonance; GE  gadolinium enhancement; gRE  global relative enhancementn whether the finding by Zagrosek et al. (13) ohat ongoing inflammation is 100% excluded in
atients in whom 1 or both of the 2 parameters,
2 signal and gRE ratio, are normal can be
pplied to larger patient groups in whom biopsy
s available.
A basic meta-analysis of most data available on
MR in human myocarditis (Table 1) (3–6,
,15–22) does not show an advantage of the
ombined approach compared with each individ-
al technique, contradicting the report of Abdel
ty et al. (5), who first described a substantial
enefit of adding T2 signal and gRE ratio to
GE imaging for myocarditis workup. This dis-
repancy most likely can also be explained by the
act that CMR findings for T2 signal and gRE
atio have never been systematically confirmed by
istopathology. Following Bayes’ principle of
oolean information processing, combining tests
ith suboptimal sensitivities and specificities
oes not necessarily improve the performance of
he combined approach. Thus, multicenter data
sing histopathological evaluation as the gold
tandard are needed.
When managing patients with inflammatory
eart disease today, it should be kept in mind that
espite the merits of CMR, which is capable of
iving clues on the presence and distribution of
nflammatory damage in the myocardium, as well
s helping to guide endomyocardial biopsy to
inimize sampling error (4), endomyocardial
iopsy is the only technique that can directly
ssess the presence and intensity of myocardial
nflammation in vivo. Therefore, it is the tech-
ique of choice if clinically indicated to differen-
iate between active and healed myocarditis. Bi-
psy samples can be safely obtained from the
ight as well as from the left ventricle, yielding a
ate of severe complications that is not signifi-
antly different from the complication rate of
tandard coronary angiography (0.1% in expe-
ienced centers) (23–25). Endomyocardial biopsy
lso provides information on the underlying cause
GE Combined Approach*
ty Speciﬁcity Sensitivity Speciﬁcity
91% 76% 83%
n  106 n  25 n  57
d late GE. Studies included in this meta-analysis are Friedrich et al. (3), n  19;
et al. (5), n  25; Hunold et al. (18), n  6; Laissy et al. (19), n  24; Ingkanisorn
et al. (22), n  71; and Baccouche et al. (unpublished data, November 2008),Table 1. Basic Meta-A
T2 te
Sensitivity S itivi
74% %
n  80 372
*No systematic comparison E, an
Roditi et al. (15), n  12; R -Aty
et al. (20), n  21; De Cob ilmaz
n  82.f inflammation, such as viral or bacterial infec-
t
m
S
w
t
m
d
r
d
f
c
m
c
t
T
r
p
e
s
b
b
m
R
h
1
R
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 2 , 2 0 0 9
F E B R U A R Y 2 0 0 9 : 1 3 9 – 1 4 2
Mahrholdt and Sechtem
Editorial Comment
141ion of the myocardium, or myocardial autoim-
une processes, such as giant cells, or Churg-
trauss syndrome. This information, however,
hich CMR imaging will not be able to obtain in
he near future, is essential for patient manage-
ent decisions. The importance of endomyocar-
ial biopsy is reflected in the current guidelines
ecommending it for basically all patients with
eveloping nonischemic heart failure, as well as
or several other nonischemic conditions (26).
Nevertheless, Zagrosek et al. (13) are to be
ongratulated on systematically collecting 18
onths of follow-up data on patients with myo-tion 2006;114:1581–90. 55:752–8.riple protocol including T2, gRE, and LGE.
heir results underscore that the time is now
eady for evaluating this combined CMR ap-
roach in a larger multicenter study (ideally with
ndomyocardial biopsy of many patients as the
tandard of reference). More data are needed
efore we can be reasonably sure that the com-
ined CMR approach holds promise to reshape
yocarditis patient management in the future.
eprint requests and correspondence: Dr. Heiko Mahr-
oldt, Robert-Bosch-Medical Center, Auerbachstrasse
10, Stuttgart 70376, Germany. E-mail: heiko.arditis who all underwent a combined CMR mahrholdt@rbk.de.1
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